@incollection{, 82657E2785DEA5A56A82C549527BCB0F , author={{Roberto P. MeissKress} and {ArielGualtieri}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}2232733 } @incollection{b0, , title={{Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries}} , author={{ FBray } and { JFerlay } and { ISoerjomataram } and { RLSiegel } and { LATorre } and { AJemal }} 10.3322/caac.21492 30207593 , journal={{CA Cancer J Clin}} 68 6 , year={2018 Nov. 2018 Sep 12} } @incollection{b1, , title={{Breast cancer in young women in Latin America: an unmet, growing burden}} , author={{ CVillarreal-Garza } and { CAguila } and { MCMagallanes-Hoyos } and { AMohar } and { EBargalló } and { AMeneses }} 10.1634/theoncologist.2013-0321 , journal={{Oncologist}} 18 12 , year={2013} } @incollection{b2, , title={{Breast Cancer-Major changes in the American Joint Committee on Cancer Eighth edition cancer staging manual}} , author={{ AEGiuliano } and { JLConnolly } and { SBEdge } and { EAMittendorf } and { HSRugo } and { LJSolin }} 10.3322/caac.21393 28294295 , journal={{CA Cancer J Clin}} 67 4 345 , year={2017 Jul 8. 2017 Mar 14. 2017 Jul 8} , note={CA Cancer J Clin} } @incollection{b3, , title={{Spotlight on the utility of the Oncotype DX(®) breast cancer assay}} , author={{ ZRSiow } and { DeBoer } and { RHLindeman } and { GJMann } and { GB }} , journal={{Int J Womens Health}} , year={2018 Feb 21} } @incollection{b4, , title={{}} 10.2147/IJWH.S124520 29503586 PMC5827461 , journal={{Review}} 10 , year={2018} } @book{b5, , title={{Online accounts of gene expression profiling in early-stage breast cancer: Interpreting genomic testing for chemotherapy decision making. Health Expect}} , author={{ ERoss } and { JSwallow } and { AKerr } and { SCunningham-Burley }} 30387238 PMC6351409 , year={2019 Feb. 2018 Nov 1} 22 } @incollection{b6, , title={{Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis}} , author={{ AOrucevic } and { REHeidel } and { JLBell }} 10.1007/s10549-016-3833-9 27206678 PMC4903105 , journal={{Breast Cancer Res Treat}} 157 3 , year={2016 Jun. 2016 May 20} } @incollection{b7, , title={{Impact of Oncotype DX breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK}} , author={{ JLoncaster } and { AArmstrong } and { SHowell } and { GWilson } and { RWelch } and { AChittalia }} 10.1016/j.ejso.2016.12.010 28111076 , journal={{Eur J Surg Oncol}} 43 5 , year={2017 May. 2017 Jan 9. 2017 Nov 23} , note={Eur J Surg Oncol} } @book{b8, , title={{Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication. ESMO Open}} , author={{ TUeno } and { SSaji } and { NMasuda } and { HIwata } and { KKuroi } and { NSato }} 10.1136/esmoopen-2018-000476.eCollection2019 30962956 PMC6435245 , year={2019 Feb 27} 4 e000476 } @incollection{b9, , title={{Cost Effectiveness of Gene Expression Profile Testing in Community Practice}} , author={{ YChandler } and { CBSchechter } and { JJayasekera } and { ANear } and { SCO'neill } and { CIsaacs }} 10.1200/JCO.2017.74.5034 29309250 PMC581540 , journal={{J Clin Oncol}} 36 6 , year={2018 Feb 20. 2018 Jan 8} } @incollection{b10, , title={{Breast Cancer in Argentina: Analysis from a Collaborative Group for the Study of Female Breast Cancer}} , author={{ MeissKress } and { RPChuit } and { RNovellije } and { ,Abalo } and { ELorusso } and { A }} 10.24218/jcet.2016.10 , journal={{J Can Epi Treat}} 1 2 , year={2016} } @incollection{b11, , title={{Can Features Evaluated in the Routine Pathologic Assessment of Lymph Node-Negative Estrogen Receptor-Positive Stage I or II Invasive Breast Cancer Be Used to Predict the Oncotype DX Recurrence Score?}} , author={{ JAuerbach } and { MimiKim } and { SusanFineberg }} , journal={{Archives of Pathology & Laboratory Medicine}} 134 11 , year={2010. November 2010} } @incollection{b12, , title={{Risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer}} , author={{ SDellapasqua } and { VBagnardi } and { MMRegan } and { NRotmensz } and { MGMastropasqua } and { GViale }} 10.1016/j.breast.2012.06.003 22749924 PMC3566763 , journal={{Breast}} 21 5 , year={2012 Oct. 2012 Jun 29} } @incollection{b13, , title={{HER2 overexpression a major risk factor for recurrence in pT1a-bN0M0 breast cancer: results from a French regional cohort}} , author={{ PRouanet } and { PRoger } and { ERousseau } and { SThibault } and { GRomieu } and { AMathieu }} 10.1002/cam4.167 24407937 PMC3930398 , journal={{Cancer Med}} 3 1 , year={2014 Feb. 2014 Jan 10} } @incollection{b14, , title={{Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score}} , author={{ BMTurner } and { KASkinner } and { PTang } and { MCJackson } and { NSoukiazian } and { MShayne }} 10.1038/modpathol.2015.50 25932962 , journal={{Mod Pathol}} 28 7 , year={2015 Jul. 2015 May 1} } @incollection{b15, , title={{A Validated Model for Identifying Patients Unlikely to Benefit From the 21-Gene Recurrence Score}} , author={{ MGage } and { MRosman } and { WMylander } and { EGiblin } and { HKim } and { LCope }} , journal={{Assay Clin Breast Cancer}} , year={2015} } @book{b16, , title={{}} 10.1016/j.clbc.2015.04.006 , year={December} 15 } @incollection{b17, , title={{Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey}} , author={{ VÖzmen } and { AAtasoy } and { EGökmen } and { MÖzdo?an } and { NGüler } and { CUras }} 10.5152/tjbh.2016.2874 28331745 PMC5351479 , journal={{J Breast Health}} 12 3 , year={2016 Jul 1. 2016 Jul} } @incollection{b18, , title={{Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset}} , author={{ MRHarowicz } and { TJRobinson } and { MADinan } and { ASaha } and { JRMarks } and { PKMarcom }} 10.1007/s10549-016-4093-4 28064383 PMC5909985 , journal={{Breast Cancer Res Treat}} 162 1 , year={2017 Feb. 2017 Jan 7} } @incollection{b19, , title={{Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors}} , author={{ DJFarrugia } and { ALandmann } and { LZhu } and { EJDiego } and { RRJohnson } and { MBonaventura }} 10.1038/modpathol.2017.41 28548119 , journal={{Mod Pathol}} 30 8 , year={2017 Aug. 2017 May 26} } @incollection{b20, , title={{Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients}} , author={{ MGHanna } and { IJBleiweiss } and { ANayak } and { SJaffer }} , journal={{Int J Breast Cancer}} 2017 1257078 , year={2017. 2017/1257078} , publisher={Epub} } @incollection{b21, , title={{Nomogram update based on TAILORx clinical trial results -Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data}} , author={{ AOrucevic } and { JLBell } and { MKing } and { APMcnabb } and { REHeidel }} 10.1016/j.breast.2019.05.006 31146185 , journal={{Breast}} 46 , year={2019 Aug. 2019 May 10} } @incollection{b22, , title={{Breast Cancer Thirty Years Later: A Comparative Study between A 1983-1984 AND A 2012-2013 Cohorts of Argentine Women}} , author={{ MeissKress } and { RPNovelli } and { JE } and { AbaloELorusso } and { AGualtieri } and { A }} 10.24218/jcet.2017.13 , journal={{J Can Epi Treat}} 1 3 , year={2017} } @incollection{b23, , title={{Breast Cancer in Argentina: Feasibility for the Implementation of the New TNM Staging System in A Middle-Income Country}} , author={{ MeissKress } and { RPNovelli } and { JEGago } and { FERobles } and { MMorales } and { SEt } and { La }} 10.24218/jcet.2018.20 , journal={{J Can Epi Treat}} 2 1 , year={2018} } @incollection{b24, , title={{Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening}} , author={{ FCVerdial } and { REtzioni } and { CDuggan } and { BOAnderson }} 28194807 PMC5701282 , journal={{J Surg Oncol}} 115 5 , year={2017 Apr. 2017 Feb 14} } @incollection{b25, , title={{Burden of early, advanced and metastatic breast cancer in The Netherlands}} , author={{ GTVondeling } and { GLMenezes } and { EPDvortsin } and { FgaJansman } and { IRKonings } and { MJPostma } and { MHRozenbaum }} 10.1186/s12885-018-4158-3 29514651 PMC5842550 , journal={{BMC Cancer}} 18 1 262 , year={2018 Mar 7} } @incollection{b26, , title={{Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography}} , author={{ GJacklyn } and { KMcgeechan } and { LIrwig } and { NHoussami } and { SMorrell } and { KBell } and { ABarratt }} 10.1007/s10549-017-4443 28822001 , journal={{Breast Cancer Res Treat}} 166 3 , year={2017 Dec. 2017 Aug 19} } @incollection{b27, , title={{Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline}} , author={{ LNHarris } and { NIsmaila } and { LMMcshane } and { FAndre } and { DECollyar } and { AMGonzalez-Angulo }} 10.1200/JCO.2015.65.2289 26858339 , journal={{J Clin Oncol}} 34 10 , year={2016 Apr 1. 2016 Feb 8} } @book{b28, , title={{PubMed Central}} PMC4933134 } @book{b29, , title={{Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA}} , author={{ PSHall } and { ASmith } and { CHulme } and { AVargas-Palacios } and { AMakris } and { LHughes-Davies }} } @book{b30, , title={{}} 10.1016/j.jval.2017.04.021 29241890 , year={2017 Dec. 2017 Jul 11} 20 } @incollection{b31, , title={{The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients}} , author={{ YLi } and { AWKurian } and { IBondarenko } and { JmgTaylor } and { RJagsi } and { KCWard } and { ASHamilton } and { SJKatz } and { TPHofer }} 10.1007/s10549-016-4086-3 28012085 PMC5243200 , journal={{Breast Cancer Res Treat}} 161 3 , year={2017 Feb. 2016 Dec 23} } @incollection{b32, , title={{Cost of breast cancer based on real-world data: a cancer registry study in Italy}} , author={{ SCapri } and { ARusso }} 28122558 PMC5267401 , journal={{BMC Health Serv Res}} 17 1 84 , year={2017 Jan 26. 1186/s12913-017-2006-9} } @incollection{b33, , title={{Global treatment costs of breast cancer by stage: A systematic review}} , author={{ LSun } and { RLegood } and { Dos-Santos-Silva IGaiha } and { SMSadique } and { Z }} 10.1371/journal.pone.0207993 30475890 PMC6258130 , journal={{PLoS One}} 13 11 e0207993 , year={2018 Nov 26. 2018} } @incollection{b34, , title={{Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Womenwith Breast Cancer}} , author={{ AVyas } and { SSMadhavan } and { USambamoorthi } and { XLPan } and { MRegier } and { HHazard } and { SKalidindi }} 10.6004/jnccn.2017.0167 29118 PMC5817990 , journal={{J Natl ComprCancNetw}} 15 11 , year={2017 Nov} } @incollection{b35, , title={{}} , journal={{Annual Report}} , year={2018} } @incollection{b36, , title={{Clinical relevance of the 21-gene Recurrence Score(®) assay in treatment decisions for patients with node-positive breast cancer in the genomic era}} , author={{ EPMamounas } and { CARussell } and { ALau } and { MPTurner } and { KSAlbain }} 10.1038/s41523-018-0082-6.eCollection 30155517 PMC6102296 , journal={{NPJ Breast Cancer}} 4 27 , year={2018 Aug 20. 2018} , note={Review} } @incollection{b37, , title={{Practical Consequences Resulting from the Analysis of a 21-Multigene Array in the Interdisciplinary Conference of a Breast Cancer Center}} , author={{ HUVoelker } and { LFrey } and { AStrehl } and { MWeigel }} , journal={{Int J Breast Cancer}} , year={2018} } @incollection{b38, , title={{}} 10.1155/2018/2047089 30112216 , journal={{Jul}} 2047089 , year={10. 2018. 2018} } @book{b39, , title={{PubMed Central}} PMC6077570 } @incollection{b40, , title={{Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer}} , author={{ AWKurian } and { IBondarenko } and { RJagsi } and { CRFriese } and { MCMcleod } and { STHawley }} 10.1093/jnci/djx239 29237009 , journal={{J Natl Cancer Inst}} 110 5 , year={2018 May 1} } @book{b41, , title={{PubMed Central}} PMC5946952 } @book{b42, , title={{The Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer with Different Histologic Subtypes. Front Genet}} , author={{ JWang } and { ZYHe } and { YDong } and { JYSun } and { WWZhang } and { SGWu }} 10.3389/fgene.2018.00638.eCollection , year={2018 Dec 17. 2018} 9 638 } @book{b43, , title={{}} , author={{ Pubmed }} 30619463 PMC6304349 }